Hong Kong Halts Use of Pfizer-BioNTech Vaccine Over Packaging Defects. Hong Kong, Macau, Vaccination and Immunization, Coronavirus (2019-nCoV), Defective Products, BioNTech SE, Pfizer Inc, Shanghai Fosun Pharmaceutical Group